ClearBridge Investments - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$14,000
-6.7%
4,0000.0%0.00%
Q2 2018$15,000
-11.8%
4,000
-6.3%
0.00%
Q1 2018$17,000
-15.0%
4,2690.0%0.00%
Q4 2017$20,000
-67.2%
4,269
-50.6%
0.00%
Q3 2017$61,000
+3.4%
8,635
+6.4%
0.00%
Q2 2017$59,000
+31.1%
8,118
+10.9%
0.00%
Q1 2017$45,000
+95.7%
7,319
+83.0%
0.00%
Q4 2016$23,000
-14.8%
4,000
-20.0%
0.00%
Q3 2016$27,000
-37.2%
5,000
-23.1%
0.00%
Q2 2016$43,000
+43.3%
6,5000.0%0.00%
Q1 2016$30,000
-41.2%
6,500
-35.0%
0.00%
Q4 2015$51,000
+30.8%
10,001
-9.1%
0.00%
Q3 2015$39,000
-98.2%
11,001
-94.9%
0.00%
-100.0%
Q2 2015$2,165,000
-22.1%
216,945
-0.7%
0.00%
-33.3%
Q1 2015$2,780,000
+27.9%
218,414
+42.1%
0.00%
+50.0%
Q4 2014$2,174,000
+2.9%
153,674
-0.0%
0.00%0.0%
Q3 2014$2,113,000
-43.4%
153,678
-36.7%
0.00%
-50.0%
Q2 2014$3,733,000
+75.2%
242,737
+94.1%
0.00%
+33.3%
Q1 2014$2,131,000125,0460.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders